Corbus Pharmaceuticals Holdings (CRBP) Amortizatization of Intangibles (2018 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) recorded quarterly Amortizatization of Intangibles of $674000.0 in Q3 2025, up 430.39% quarter-over-quarter from -$204000.0 in Q2 2025, and down 69.08% on a YoY basis from $2.2 million in Q3 2024.
Corbus Pharmaceuticals Holdings (CRBP) Amortizatization of Intangibles (2018 - 2025) Analysis & Trends
Corbus Pharmaceuticals Holdings' Amortizatization of Intangibles history runs 8 years deep, the most recent figure standing at $674000.0 for Q3 2025.
- In Q3 2025, Amortizatization of Intangibles fell 69.08% year-over-year to $674000.0; the TTM figure through Sep 2025 stood at $1.5 million (down 41.82% YoY), while the FY2024 annual figure was $3.3 million, up 557.51% from the prior year.
- Amortizatization of Intangibles was $674000.0 for Q3 2025 at Corbus Pharmaceuticals Holdings, up from -$204000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $2.2 million in Q3 2024 to a low of -$838299.0 in Q2 2022.
- Historically, Amortizatization of Intangibles has averaged $267512.5 across 5 years, with a median of $173810.0 in 2021.
- Biggest YoY gain for Amortizatization of Intangibles was 6870.72% in 2022; the steepest drop was 582.31% in 2022.
- A 5-year view of Amortizatization of Intangibles shows it stood at $339286.0 in 2021, then tumbled by 295.92% to -$664742.0 in 2022, then soared by 112.03% to $80000.0 in 2023, then jumped by 933.75% to $827000.0 in 2024, then retreated by 18.5% to $674000.0 in 2025.
- The last three Amortizatization of Intangibles figures came in at $674000.0 (Q3 2025), -$204000.0 (Q2 2025), and $204000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 135.08 Mn | 107.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 674,000.00 |
| Sep 30, 2025 | 674,000.00 |
| Jun 30, 2025 | -204,000.00 |
| Jun 30, 2025 | -204,000.00 |
| Mar 31, 2025 | 204,000.00 |
| Mar 31, 2025 | 204,000.00 |
| Dec 31, 2024 | 827,000.00 |
| Dec 31, 2024 | 827,000.00 |
| Sep 30, 2024 | 2.18 Mn |
| Sep 30, 2024 | 2.18 Mn |
| Jun 30, 2024 | 132,000.00 |
| Jun 30, 2024 | 132,000.00 |
| Mar 31, 2024 | 188,000.00 |
| Mar 31, 2024 | 188,000.00 |
| Dec 31, 2023 | 80,000.00 |
| Dec 31, 2023 | 80,000.00 |
| Sep 30, 2023 | 147,000.00 |
| Sep 30, 2023 | 147,000.00 |
| Jun 30, 2023 | 77,092.00 |
| Jun 30, 2023 | 77,092.00 |